Marsh & McLennan Companies, Inc. (NYSE:MRSH) Given Average Rating of “Hold” by Analysts

Shares of Marsh & McLennan Companies, Inc. (NYSE:MRSHGet Free Report) have received an average rating of “Hold” from the eighteen research firms that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell rating, ten have given a hold rating, six have given a buy rating and one has given a strong buy rating to the company. The average 12 month target price among brokerages that have covered the stock in the last year is $203.5625.

MRSH has been the subject of a number of research analyst reports. Morgan Stanley lowered their target price on Marsh & McLennan Companies from $195.00 to $190.00 and set an “equal weight” rating for the company in a report on Monday, April 6th. JPMorgan Chase & Co. lowered their target price on Marsh & McLennan Companies from $226.00 to $206.00 and set an “overweight” rating for the company in a report on Thursday, April 9th. Raymond James Financial upgraded Marsh & McLennan Companies from an “outperform” rating to a “strong-buy” rating and set a $225.00 target price for the company in a report on Tuesday, February 17th. Piper Sandler lowered their target price on Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating for the company in a report on Tuesday. Finally, Citigroup upgraded Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 target price for the company in a report on Wednesday, May 6th.

View Our Latest Stock Analysis on Marsh & McLennan Companies

Marsh & McLennan Companies Price Performance

Marsh & McLennan Companies stock opened at $160.70 on Thursday. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 1.28. The company has a market capitalization of $77.63 billion, a PE ratio of 20.09, a P/E/G ratio of 2.36 and a beta of 0.65. Marsh & McLennan Companies has a 12 month low of $158.16 and a 12 month high of $235.78. The stock has a 50-day moving average price of $166.27 and a two-hundred day moving average price of $172.72.

Marsh & McLennan Companies (NYSE:MRSHGet Free Report) last posted its quarterly earnings data on Thursday, April 16th. The financial services provider reported $3.29 EPS for the quarter, topping analysts’ consensus estimates of $3.21 by $0.08. The company had revenue of $7.30 billion for the quarter. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The firm’s quarterly revenue was up 7.6% compared to the same quarter last year. Analysts expect that Marsh & McLennan Companies will post 10.37 EPS for the current year.

Insider Buying and Selling

In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,655 shares of the firm’s stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $183.30, for a total value of $3,052,861.50. Following the completion of the sale, the chief executive officer owned 116,811 shares of the company’s stock, valued at approximately $21,411,456.30. This trade represents a 12.48% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 0.38% of the company’s stock.

Institutional Investors Weigh In On Marsh & McLennan Companies

Hedge funds have recently added to or reduced their stakes in the company. Numerai GP LLC grew its stake in Marsh & McLennan Companies by 966.2% in the third quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider’s stock valued at $7,501,000 after acquiring an additional 33,729 shares during the period. Swiss Life Asset Management Ltd grew its stake in Marsh & McLennan Companies by 9.5% in the fourth quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider’s stock valued at $24,960,000 after acquiring an additional 11,648 shares during the period. Rockland Trust Co. grew its stake in Marsh & McLennan Companies by 801.6% in the third quarter. Rockland Trust Co. now owns 12,073 shares of the financial services provider’s stock valued at $2,433,000 after acquiring an additional 10,734 shares during the period. Barclays PLC boosted its position in shares of Marsh & McLennan Companies by 41.7% during the third quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider’s stock valued at $443,844,000 after buying an additional 647,987 shares during the last quarter. Finally, Bridges Investment Management Inc. boosted its position in shares of Marsh & McLennan Companies by 4.4% during the third quarter. Bridges Investment Management Inc. now owns 76,196 shares of the financial services provider’s stock valued at $15,356,000 after buying an additional 3,177 shares during the last quarter. Institutional investors and hedge funds own 87.99% of the company’s stock.

Marsh & McLennan Companies Company Profile

(Get Free Report)

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

Recommended Stories

Analyst Recommendations for Marsh & McLennan Companies (NYSE:MRSH)

Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.